Suchergebnisse - "van der Kraaij, Gayle"

PubPharm (7)

1

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling

enthalten in: The Journal of investigative dermatology | 2024

von van Huizen, A. | Bank, P. | van der Kraaij, G. | +12

2

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis : Three-year follow-up data of a single-blind randomized controlled trial

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von van Huizen, A. | van der Kraaij, G. | Busard, C. | +10

CommentIn: J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1685-1686. - PMID 37622224

3

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis : First-Year Results of a Single-Blind Randomized Controlled Trial

enthalten in: The Journal of investigative dermatology | 2022

von van der Kraaij, G. | Busard, C. | van den Reek, J. | +14

4

A man with a rare disfiguring cutaneous manifestation of sarcoidosis

enthalten in: Nederlands tijdschrift voor geneeskunde | 2022

von Mo, C. | van der Kraaij, G. | van der Leest, R.

5

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

enthalten in: JAMA dermatology | 2022

von van Huizen, A. | Menting, S. | Gyulai, R. | +98

ErratumIn: JAMA Dermatol. 2024 Jan 10;:. - PMID 38198172

6

Towards More Shared Decision Making in Dermatology : Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments

enthalten in: Acta dermato-venereologica | 2020

von Vermeulen, F. | van der Kraaij, G. | Tupker, R. | +9

7

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis : A Multicentre Daily Practice Cohort Study

enthalten in: Acta dermato-venereologica | 2018

von van den Reek, J. | van Vugt, L. | van Doorn, M. | +15

1
[1]